Hospital vs. Cell Phone Number Follow-Up Randomization Study

NCT ID: NCT01620827

Last Updated: 2016-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being conducted to evaluate the hypothesis that study subjects will be more responsive to follow-up phone calls made from personal cell phone numbers than from hospital landline numbers. To evaluate this, study subjects previously enrolled in a cardiac biomarker study (the Early Identification of Acute Coronary Syndrome study) were randomized to receive their follow-up phone calls (the calls associated with the Early ID study occur at 30 days and 1 year after initial enrollment) from either a hospital office landline or from the personal cell phones of the research assistants making these calls. This was done as a 1:1 randomization. The number of call attempts required to reach the study subjects were recorded as the calls were made and the date of successful follow-up was recorded once contact was made.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subject Follow-up

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hospital Landline

Subjects in this arm have all of their follow-up phone calls placed from a hospital landline number.

Group Type ACTIVE_COMPARATOR

Hospital Landline Phone Calls

Intervention Type OTHER

Follow-up phone calls are made from the hospital landline phones in a research office

Private Cell Phone

Subjects in this arm have all of their follow-up phone calls placed from a private cell phone number.

Group Type ACTIVE_COMPARATOR

Private Cell Phone Calls

Intervention Type OTHER

Follow-up phone calls are made from the private cell phones of research assistants

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hospital Landline Phone Calls

Follow-up phone calls are made from the hospital landline phones in a research office

Intervention Type OTHER

Private Cell Phone Calls

Follow-up phone calls are made from the private cell phones of research assistants

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Enrollment in the Early Identification of Acute Coronary Syndrome study
* Working telephone numbers

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Judd Hollander, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUP-FURS-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.